In a historic milestone for the field of cosmetic breast surgery, we are delighted to announce the formation of the American Association of Cosmetic Breast Surgeons (AACBS). This visionary organization, dedicated to advancing the art and science of cosmetic breast surgery, proudly welcomes Dr. John Zannis, a distinguished Plastic Surgeon, […]
COSMOSS Partners With Chopra Foundation ‘Never Alone’ to Support Mental Health Awareness
Kate Moss, Founder of COSMOSS, and Deepak Chopra, Founder of Chopra Foundation, are proud to announce a new partnership to support mental health and wellbeing between COSMOSS and the Chopra Foundation. From January 2024, COSMOSS, the Award-Winning Wellness brand by Kate Moss, will be working with Chopra Foundation to support […]
Tampa General Hospital Named One of Newsweek’s Best Smart Hospitals for 2024
Tampa General Hospital (TGH) has been recognized as one of the World’s Best Smart Hospitals for 2024 by Newsweek and Statista. This prestigious global accolade is a testament to Tampa General’s commitment to harnessing cutting-edge technology to enable world-class patient care, improve care coordination and streamline hospital operations. “As a […]
MGI Partners with Gencell to Expand Genomics in Latin America
MGI, a company committed to building core tools and technology to lead life science, is thrilled to announce a strategic partnership with Gencell, a health company focused on molecular biology and genetic services in Colombia and the broader LATAM region. This collaboration capitalizes on the expertise and established market presence […]
Unlocking the Future of Drug Discovery with Artificial Intelligence
BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the AI-driven revolution in drug discovery. BOSTON, Sept. 22, 2023 /PRNewswire/ […]
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced positive topline results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for PADCEV® (enfortumab vedotin-ejfv) in combination with KEYTRUDA® (pembrolizumab) versus chemotherapy in patients with previously untreated locally advanced or […]
NYU Langone Health ranked No. 1 in the Nation for Quality and Patient Safety
NYU Langone Health has once again been named No. 1 in the nation for quality and patient safety by Vizient, Inc., a leading healthcare performance improvement organization that determines its rankings based on mortality and infection rates, patient experience scores, and other critical quality measures. At a ceremony hosted by […]
Combining best-in-class AI-powered Technologies for Musculoskeletal (MSK) Imaging Workflows – ImageBiopsy Lab and Radiobotics sign Collaboration Agreement
ImageBiopsy Lab (Vienna, Austria) and Radiobotics (Copenhagen, Denmark) have teamed up to advance the use of Artificial-Intelligence (AI) supported disease diagnostics for musculoskeletal (MSK), orthopaedic, and trauma use-cases in the DACH region. Globally, musculoskeletal conditions affect a larger population than circulatory or respiratory disorders. Despite this, diagnostic methods often remain […]
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) and the Fast Track Designation under the Generating Antibiotic Incentives Now (GAIN) Act […]
Life Time Expands to Connecticut with First Athletic Country Club and Life Time Living Luxury Residences in Downtown Stamford
Life Time (NYSE:LTH), the nation’s premier healthy lifestyle brand, today opened its first athletic country club in Connecticut with a nearly 52,000-square foot athletic country club and 10,000-square-foot rooftop beach club in downtown Stamford. The vertically integrated tower featuring 290 luxury residences for lease also opened, licensed under the Life […]
